Exploring Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-Associated Protein 9 (CRISPR-Cas9) as a Therapeutic Modality for Cancer: A Scoping Review · Balasubramanian A, Veluswami K, Rao S et al.

Introduction and background

Cancer stands as a significant global health challenge, with nearly two million annual diagnoses, making it the second leading cause of death in the United States [1]. The National Cancer Institute has set a goal to achieve a minimum 50% reduction in the overall cancer death rate by the year 2047 while simultaneously enhancing cancer care for all individuals [1]. Cancer is inherently a genetic disease, arising from the gradual accumulation of genetic alterations that disrupt growth signals within the body [2]. Consequently, the management of cancer is said to be a highly complex process [3]. The conventional treatments of chemotherapy and radiation therapy, either alone or in combination, have shown improved survival rates [4], but their effectiveness is tempered by detrimental side effects such as chemotoxicity, nausea, vomiting, diarrhea, oral mucositis, drug resistance, and so on, which can significantly impact daily life [4-6]. Another widely acknowledged modality is surgery [7]. However, it is an invasive procedure and may not be universally accessible, particularly to lower-income households with an increased risk of postoperative complications [8] and recurrence [9]. These limitations impose a significant mental toll on individuals, giving rise to psychosocial concerns [5]. With the surging rates of cancer incidence and associated mortality, there has been a pressing need for a broader range of treatment modalities that offer enhanced prognostic outcomes.

Advancements in science and research have paved the way for groundbreaking modalities that were once considered implausible, helping in the discovery of gene-specific treatments, namely immunotherapy and gene therapy. Immunotherapy harnesses the body’s immune system to target and combat cancer cells in the form of cancer vaccines, checkpoint blockade therapy, and adoptive cell transfer [10]. On the other hand, gene therapy involves the introduction or modification of genetic material to treat or prevent diseases, holding immense promise for personalized and precise cancer treatments [11]. These cutting-edge techniques signify a paradigm shift in the approach to cancer care, offering a highly targeted approach with improved outcomes. However, it is crucial to acknowledge that the satisfactory outcomes were only limited to a subset of cancer types [12]. Moreover, initial attempts at gene therapy raised concerns about insertional mutations [13]. Traditionally, gene delivery to the target tissues relied on viral vectors. Challenges included handling viral vectors due to the risk of vector-related toxicity, high cost, and time-consuming labor-intensive work to reduce this toxicity [14] and adaptive immunity of the body, reducing the clinical response to the viral vectors and ultimately the efficacy of viral vectors [15].

Overcoming the limitations of gene therapy and allowing a significant shift from merely introducing genes to the art of genome editing instead was the invention of a gene editing tool, namely clustered regularly interspaced short palindromic repeats (CRISPR). As mentioned by Khan et al., CRISPR is a novel family of repetitive DNA sequences that belong to prokaryote genomes that enables precisely editing, adding, or deleting specific DNA sequences with unparalleled accuracy and carries the potential to cure cancer (Figure 1) [16]. Once considered ambitious speculation, genetic manipulation by CRISPR has emerged as a revolutionary approach to fighting diseases, particularly cancer. This paper aims to explore the role of CRISPR as a groundbreaking tool at the forefront of cancer research and its potential to reshape the way we treat cancer.

Figure. CRISPR for genome editingCRISPR, clustered regularly interspaced short palindromic repeatsCreated with BioRender.com; Image credit: Abirami Balasubramanian (See the original article for the figure.)